The Saudi Arabia Digital Diabetes Management Market size was valued at USD 124.9 million in 2023 and is projected to reach USD 226.86 million by 2032, exhibiting a CAGR of 8.9 % during the forecasts period.The digital diabetes management market in Saudi Arabia is experiencing rapid growth, fueled by increasing diabetes prevalence, technological advancements, and governmental initiatives promoting healthcare digitalization. Diabetes poses a substantial public health challenge in Saudi Arabia, with high prevalence rates influenced by factors such as sedentary lifestyles, unhealthy diets, and genetic predispositions. Digital diabetes management solutions encompass various technologies, including mobile apps, wearable devices, continuous glucose monitoring (CGM) systems, and telemedicine platforms. These innovations empower patients with tools for self-monitoring, education, and remote healthcare access. Key drivers of market expansion include the growing adoption of smartphones and internet connectivity, which facilitate the use of mobile health (mHealth) applications for real-time monitoring of blood glucose levels and lifestyle management. These technologies enable patients and healthcare providers to track glucose trends, monitor medication adherence, and develop personalized care plans, thereby enhancing treatment outcomes and reducing diabetes-related complications. Government initiatives in Saudi Arabia aimed at enhancing healthcare infrastructure and promoting digital transformation further accelerate market growth. The Kingdom's Vision 2030 agenda prioritizes technology's role in improving healthcare delivery and outcomes, fostering investments in digital health solutions. Challenges include ensuring data privacy and security, adhering to regulatory requirements, and addressing disparities in digital literacy and access across different demographic groups. Recent developments include: In February 2023, Digital Diagnostics, creator of LumineticsCore (previously named IDx-DR), the initial FDA-approved autonomous AI system for diagnosing diabetic retinopathy, partnered with Tamer Healthcare, an integrated healthcare firm in Saudi Arabia, to boost healthcare and innovation in the kingdom. , In June 2023, Integrative Health, a health technology company headquartered in Saudi Arabia, announced its acquisition of Nala, another health technology platform based in the kingdom . Key drivers for this market are: Saudi Arabia has witnessed a significant increase in diabetes cases, driven by lifestyle changes, urbanization, and an aging population. This demographic shift increases the demand for effective diabetes management solutions.. Potential restraints include: Uneven distribution of healthcare resources and infrastructure across different regions of Saudi Arabia may limit access to digital diabetes management solutions, especially in rural areas.. Notable trends are: There is a growing emphasis on designing user-friendly interfaces and intuitive mobile apps that enhance patient engagement and adherence to treatment plans..

The Saudi Arabia Diabetes Devices Market was valued at USD 200.72 Million in 2024 and is projected to grow to USD 325.66 Million by 2030, with a compound annual growth rate (CAGR) of 8.4% from 2025 to 2030.

The Saudi Arabia Diabetes Devices Market size was valued at USD 199.6 million in 2023 and is projected to reach USD 345.20 million by 2032, exhibiting a CAGR of 8.14 % during the forecasts period. Saudi Arabia diabetes devices are medical devices used to diagnose, control, prevent, and treat diabetes mellitus in patients. Such devices include blood glucose meters, CGMs, insulin pumps, and insulin pens used by people with diabetes. These devices are related to the constant measurement of blood glucose levels and controlling diabetes using insulin and other symptoms associated with it. Examples include inpatient, outpatient, and community care settings such as hospitals, outpatient pharmacies, and self-care settings in cases of diabetes. Some of the patterns shaping the market are the emerging focuses in extended wearables for CGM, digital health adoption for Home & Remote Monitoring and Telemedicine, and the rise in Insulin Delivery Systems for Personalized Diabetes Management. New cases of diabetes, focusing on the healthcare system improvement by the government, and a growing number of people who have enhanced awareness of the condition drive the growth of the Saudi Arabia diabetes devices market. Recent developments include: In February 2023, Insulet Corporation acquired the assets of a California-based company, Automated Glucose Control LLC (AGC), specializing in automated insulin delivery technology , In February 2023, Insulet Corporation acquired the patents for insulin pumps from Bigfoot Biomedical (Bigfoot), a company specializing in insulin delivery technologies , In August 2022, Abbott entered a strategic agreement with WW International, Inc. (WeightWatchers). With the help of this partnership, both companies will combine WeightWatchers weight management program for people with diabetes with Abbott's line of FreeStyle Libre products to produce a seamless mobile experience, offering knowledge & insights to improve their diet, lower their blood sugar levels, and, ultimately, take back control of their health , In August 2022, Insulet Corporation received FDA clearance for its Omnipod 5 Automated Insulin Delivery System (Omnipod 5) for individuals aged 2 and above with type 1 diabetes .

The Middle East and Africa Diabetes Care Devices market, valued at $2.43 billion in 2025, is projected to experience robust growth, driven by rising diabetes prevalence, increasing healthcare expenditure, and expanding awareness of diabetes management. The market's Compound Annual Growth Rate (CAGR) of 4.12% from 2025 to 2033 indicates a significant expansion in market size over the forecast period. Key growth drivers include the increasing adoption of advanced continuous glucose monitoring (CGM) systems offering improved glycemic control, the rising affordability of insulin pumps and other management devices, and governmental initiatives focused on improving diabetes care infrastructure across the region. Growth is further fueled by the increasing prevalence of type 2 diabetes, linked to lifestyle changes such as urbanization and dietary shifts. While challenges remain, such as affordability constraints in certain segments of the population and limited healthcare access in some regions, these are being offset by technological advancements and government interventions aimed at improving healthcare accessibility. The market segmentation highlights the significant contribution of self-monitoring blood glucose devices (SMBG), particularly glucometers and test strips, alongside the growing adoption of CGMs and insulin pumps which represent premium segments with high growth potential. Geographically, countries like Saudi Arabia, Iran, and Egypt are expected to dominate the market due to their high diabetes prevalence and relatively developed healthcare infrastructure. The competitive landscape is marked by the presence of major multinational players like Dexcom, Medtronic, Roche, and Novo Nordisk, alongside several regional companies. These companies are strategically investing in R&D, product innovation, and expansion of their distribution networks to cater to the diverse needs of the market. The continuous innovation in device technology, focusing on improved accuracy, convenience, and patient-centric design, will further stimulate market growth. Future market dynamics will likely be shaped by the increasing adoption of telehealth and remote monitoring technologies, the development of closed-loop insulin delivery systems, and the expanding role of digital health solutions in diabetes management. This trend towards personalized and technologically advanced diabetes care is set to drive further growth and transformation within the Middle East and Africa Diabetes Care Devices market in the coming years. Recent developments include: August 2023: Nemaura Medical has received approval from the Saudi Food and Drug Authority (SFDA) for its non-invasive wearable glucose sensor, sugarBEAT. This approval follows more than a year of partnership with the SFDA through the company’s licensee in the Middle East, TPMENA, from which Nemaura previously received a provisional purchase order for 1.7 million sensors and 17,000 devices., October 2022: Becton, Dickinson, and Company and Biocorp announced that they signed an agreement to use connected technology to track adherence to self-administered drug therapies, like biologics. To support biopharmaceutical companies in their efforts to improve the adherence and outcomes of injectable drugs, the two companies would integrate Biocorp's Injay technology-a solution designed to capture and transmit injection events using Near Field Communication technology to the BD UltraSafe Plus Passive Needle Guard used with pre-fillable syringes.. Notable trends are: Continuous glucose monitoring segment is expected to witness highest growth rate over the forecast period.

The GCC And UAE Diabetes Devices Market size was valued at USD 2.92 billion in 2023 and is projected to reach USD 4.72 billion by 2032, exhibiting a CAGR of 7.1 % during the forecasts period. The GCC and UAE Diabetes Devices Market specifically covers devices that are prescribed and utilized for diabetes control within the GCC, consisting of Bahrain, Kuwait, Oman, Qatar, Saudi Arabia, and the UAE. Such apparatus include blood glucose monitor, CGM, insulin pumps, and lancets. Examples include measuring blood glucose level and managing the Insulin and diabetes to reduce other health risks taken at least once a day. It applies to use in hospitals, clinic and in home care Handy tools range from autoprocessing and automation to standard features which include logging, alarms as well as a trend chart. Some of the trends that can spur this market include growth of diabetes around the globe as a result of alterations in life patterns, realization of new and enhanced monitoring techniques, and the emerging recognition of self- management of diabetes. Further, trends targets are associated with actions such as government plans for enhancement of diabetic treatment, introduction of digital methodologies for distance monitoring, availability of convenient, non-invasive devices.

The Middle East and Africa Continuous Glucose Monitoring (CGM) market is experiencing robust growth, projected to reach $261.03 million by 2025 and maintain a Compound Annual Growth Rate (CAGR) of 12.83% from 2025 to 2033. This expansion is driven by several key factors. Rising prevalence of diabetes, particularly in countries like Saudi Arabia, Egypt, and Iran, fuels the demand for advanced glucose management solutions. Increased awareness of the benefits of CGM systems, such as improved glycemic control and reduced risk of complications, is also a significant driver. Furthermore, the growing adoption of telehealth and remote patient monitoring technologies is facilitating greater access to CGM and enhancing patient outcomes. The market is segmented by components (sensors, durables), distribution channels (online, offline), and geography, offering various avenues for growth. Leading players like Abbott Diabetes Care, Dexcom, and Medtronic are actively investing in product innovation and market expansion to capitalize on the significant market opportunity. Competitive pricing strategies and the introduction of user-friendly, technologically advanced devices are contributing to market expansion. While challenges like high cost of CGM systems and limited healthcare infrastructure in some regions exist, the overall market outlook remains positive, suggesting continued strong growth in the coming years. The market's regional performance is expected to vary. Saudi Arabia, with its well-established healthcare infrastructure and high diabetes prevalence, is likely to be a key contributor to market growth. Iran and Egypt, despite having relatively lower healthcare spending per capita, are anticipated to experience significant CGM adoption due to an increasing diabetic population and the rising accessibility of affordable solutions. South Africa and other regions in sub-Saharan Africa present considerable opportunities albeit slower growth due to socioeconomic factors and healthcare access challenges. The market will witness a surge in demand for both online and offline distribution channels to cater to diverse consumer preferences and regional specificities. Technological advancements, such as the development of smaller, less invasive sensors and improved data analytics capabilities, are poised to further drive market expansion. Furthermore, increased collaboration between manufacturers, healthcare providers, and government agencies can facilitate wider adoption of CGM and improved diabetes management across the Middle East and Africa. Recent developments include: February 2023: Dexcom announced the launch of Dexcom G7 Continuous Glucose Monitoring in South Africa. The Dexcom G7 includes the Dexcom Share and Follow feature. The user of the Dexcom Follow app can also create customizable alerts and alarms. Additionally, the G7 system provides a more comprehensive view of glucose levels over time, giving people with diabetes and their healthcare providers more information to make decisions about treatment and diabetes management., June 2022: Abbott announced that it's developing a new bio-wearable that would continuously monitor glucose and ketone levels in one sensor. The glucose-ketone sensor was expected to be the same size as Abbott's FreeStyle Libre 3 sensor, the world's smallest and thinnest continuous glucose monitoring sensor, and will connect to Abbott's digital ecosystem, including personal and caregiver mobile apps and cloud-based data management software for remote monitoring by healthcare professionals.. Notable trends are: The sensors segment holds the highest market share in the Middle East and African Continuous Glucose Monitoring Market in the current year.

The size of the Middle East and Africa Continuous Glucose Monitoring Market was valued at USD 261.03 Million in 2023 and is projected to reach USD 607.66 Million by 2032, with an expected CAGR of 12.83% during the forecast period. The MEA Continuous Glucose Monitoring (CGM) market has been growing at a moderate level due to the growing incidence of diabetes in different nations such as Saudi Arabia, South Africa, and UAE. Other related devices include CGM devices that help the diabetic patient to continually get real time glucose reading hence easing the management of the condition. The adoption is growing due to an individuals’ knowledge of the newest technologies around diabetes management and because of the increased spending on healthcare infrastructure. However, there is high cost of the technology, restricted access to remote area and the legal restraints that are there even today. Other trends are the alliances of overseas health care organizations with domestic counterparts for increasing the coverage of CGM solutions. Recent developments include: February 2023: Dexcom announced the launch of Dexcom G7 Continuous Glucose Monitoring in South Africa. The Dexcom G7 includes the Dexcom Share and Follow feature. The user of the Dexcom Follow app can also create customizable alerts and alarms. Additionally, the G7 system provides a more comprehensive view of glucose levels over time, giving people with diabetes and their healthcare providers more information to make decisions about treatment and diabetes management., June 2022: Abbott announced that it's developing a new bio-wearable that would continuously monitor glucose and ketone levels in one sensor. The glucose-ketone sensor was expected to be the same size as Abbott's FreeStyle Libre 3 sensor, the world's smallest and thinnest continuous glucose monitoring sensor, and will connect to Abbott's digital ecosystem, including personal and caregiver mobile apps and cloud-based data management software for remote monitoring by healthcare professionals.. Key drivers for this market are: Rapidly Increasing Incidence and Prevalence of Diabetes, Technological Advancements in the Market. Potential restraints include: Monopolized Supply Chain and High Cost of Devices. Notable trends are: The sensors segment holds the highest market share in the Middle East and African Continuous Glucose Monitoring Market in the current year.

The Middle East and Africa (MEA) diabetes treatment market, valued at $1.62 billion in 2025, is projected to experience steady growth, driven by rising prevalence of diabetes, increasing awareness of the disease, and improved access to healthcare. A compound annual growth rate (CAGR) of 3.78% is anticipated from 2025 to 2033, indicating a consistent market expansion. This growth is fueled by several factors. Firstly, the region is witnessing a surge in diabetes cases, largely attributed to lifestyle changes like increased urbanization, sedentary lifestyles, and unhealthy diets. Secondly, greater awareness campaigns and improved access to diagnostic tools are leading to earlier diagnosis and treatment initiation, boosting market demand. Government initiatives focused on diabetes management and prevention also contribute to the market’s positive trajectory. The market is segmented by insulin type (basal/long-acting, bolus/fast-acting, traditional human, combination, biosimilars) and geography, with countries like Saudi Arabia, Iran, Egypt, and South Africa representing significant market shares. Competition is fierce among major players like Novo Nordisk, Sanofi Aventis, and Eli Lilly, along with emerging biosimilar manufacturers. Challenges remain, however, including affordability concerns in certain regions and the need for continuous advancements in insulin delivery systems to improve patient compliance and outcomes. The market segmentation reveals significant opportunities for targeted strategies. Long-acting insulins are expected to maintain substantial market share due to their convenience and improved glycemic control. The increasing adoption of biosimilars is also expected to drive cost-effectiveness, impacting the market dynamics. Geographic variations in market penetration reflect the disparities in healthcare infrastructure and access across the MEA region. Future growth will depend on successful strategies to address these regional differences and improve access to affordable, high-quality diabetes care across the region, including increased investment in public health initiatives and innovative treatment approaches. Furthermore, the development and adoption of digital health technologies for diabetes management presents a significant future growth opportunity. Recent developments include: February 2023: South Korea-based EOFlow, a provider of wearable drug delivery solutions, received certification from the United Arab Emirate (UAE) Ministry of Health and Prevention (MOHAP) to commercialize its wearable insulin pump 'EOPatch' and its controller 'ADM' as well as its smartphone app 'Narsha'. EOFlow said that this UAE launch marks the first entry of EOPatches in the Middle East. The UAE is EOFlow's second overseas sales region after Europe. It was expected to serve as a bridgehead for exporting wearable insulin pump solutions to Middle East and North Africa (MENA) countries., December 2022: Eli Lilly partnered with generics maker Eva to boost insulin access in Africa. In a licensing agreement with generics drugmaker Eva Pharma of Egypt, Lilly was expected to deliver active pharmaceutical ingredients at a reduced cost for its human and analog insulin. Lilly also was expected to provide a 'pro-bono transfer' of the technology needed to formulate, fill and finish vials and cartridges.. Notable trends are: Biosimilar Insulin Segment Holds Highest Market Share in Middle-East and Africa Human Insulin Market..

Snapshot img

Saudi Arabia Healthcare IT Market Size 2025-2029

The Saudi Arabia healthcare IT market size is forecast to increase by USD 2.33 billion at a CAGR of 10.7% between 2024 and 2029.

The market is experiencing significant growth due to several key factors. The increasing prevalence of chronic diseases is driving the need for advanced IT solutions to manage patient data and improve healthcare delivery. Telemedicine and other digital health solutions are gaining popularity, enabling remote patient monitoring and virtual consultations, which are increasing accessibility and convenience for patients. However, the lack of skilled IT professionals In the healthcare sector poses a challenge to the implementation and effective utilization of these technologies. These trends and challenges highlight the importance of investing in IT infrastructure and workforce development to meet the evolving needs of the healthcare industry.

What will be the Size of the market During the Forecast Period?

Request Free Sample

The market is experiencing significant growth due to the increasing prevalence of chronic diseases and the aging population. Automation, telemedicine, digital health, social media analytics, and internet-enabled mobile technologies are transforming healthcare delivery, enabling more efficient communication and collaboration among healthcare providers. Electronic Health Records (EHRs) and Healthcare Information Exchanges (HIE) are streamlining administrative tasks, reducing errors, and improving patient safety.



Healthcare analytics facilitates medical research by analyzing anonymized data from studies and clinical trials, enhancing the accuracy and effectiveness of treatments. Telehealth and telemedicine are bridging geographical gaps, allowing remote consultation and monitoring for patients. Communication tools and healthcare analytics are optimizing workflows, enabling healthcare teams to collaborate more effectively and deliver better patient care.

How is this market segmented and which is the largest segment?

The market research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in 'USD billion' for the period 2025-2029, as well as historical data from 2019-2023 for the following segments.

Component

  Services
  Software
  Hardware


End-user

  Healthcare providers
  Healthcare payers


Method

  Acute care
  Post-acute care
  Ambulatory care


Geography

  Saudi Arabia

By Component Insights

The services segment is estimated to witness significant growth during the forecast period.

The Saudi Arabian healthcare IT market is experiencing significant growth due to the government's focus on leveraging technology for efficient and effective healthcare delivery. Key services in this market include Electronic Medical Records (EMR), telemedicine, Health Information Exchange (HIE), and patient engagement solutions. EMR systems enable healthcare providers to digitally manage patient health records, enhancing access to accurate and complete patient information. Leading providers have been adopted by several hospitals in Saudi Arabia, including King Saud Medical City in Riyadh, resulting in improved patient care, clinical decision-making, and operational efficiency. Telemedicine and HIE facilitate remote consultations and seamless data sharing between healthcare facilities, addressing healthcare accessibility challenges in remote areas and reducing redundant tests and administrative tasks.

Digital health solutions, including social media analytics, Internet-enabled mobile devices, and artificial intelligence, are also gaining traction in enhancing patient care and engagement, as well as disease surveillance and population health management. The market scenario is further driven by the aging population, increasing healthcare costs, and the need for personalized medicine and predictive analytics. The research team anticipates continued growth in this sector, with a focus on improving patient outcomes, patient-centric care, and resource allocation in hospitals and clinics.

Get a glance at the market report of share of various segments Request Free Sample

Market Dynamics

Our market researchers analyzed the data with 2024 as the base year, along with the key drivers, trends, and challenges. A holistic analysis of drivers will help companies refine their marketing strategies to gain a competitive advantage.

What are the key market drivers leading to the rise in adoption of Saudi Arabia Healthcare IT Market?

Increasing number of chronic diseases is the key driver of the market.

The market is experiencing significant growth due to the increasing prevalence of chronic diseases In the aging population. Chronic diseases, such as diabetes, require ongoing management and medical attention, leading to a higher demand for automated information systems and digital health tools. Telemedicine a

The size of the Hospital Supplies Market in Saudi Arabia market was valued at USD 1.06 Million in 2023 and is projected to reach USD 1.57 Million by 2032, with an expected CAGR of 5.80% during the forecast period. The hospital supplies market in Saudi Arabia is a rapidly growing sector, fueled by the country’s ongoing healthcare infrastructure development and its commitment to providing high-quality medical services. As Saudi Arabia works toward its Vision 2030 initiative, healthcare has emerged as a priority, with significant investments in hospitals, clinics, and medical facilities. The hospital supplies market encompasses various products, including medical consumables, surgical instruments, patient care equipment, infection control products, and diagnostic tools. Saudi Arabia’s aging population is leading to an increased prevalence of chronic diseases such as diabetes, cardiovascular disorders, and cancer. This trend is driving demand for hospital supplies, particularly those related to long-term patient care, diagnostics, and chronic disease management. Recent developments include: In November 2022, on-site healthcare management service provider Saudi Response Plus Medical launched a specialized ambulance center and medical training center in Riyadh within just three years of entering the Saudi market., In July 2022, the Saudi Red Crescent Authority and The Helicopter Company, fully owned by the Saudi Public Investment Fund (PIF), signed an agreement for the inauguration of the Saudi Air Ambulance Service in the Kingdom. The Service has been launched in Riyadh and will expand throughout the Kingdom in several phases.. Key drivers for this market are: The Saudi government has significantly increased its healthcare budget to improve access to medical services and reduce reliance on foreign healthcare providers. This includes procurement of essential hospital supplies to ensure the highest standards of patient care. . Potential restraints include: A significant portion of Saudi Arabia’s hospital supplies is imported from international markets, making the industry vulnerable to global supply chain disruptions, currency fluctuations, and trade regulations. . Notable trends are: Saudi Arabia is embracing digital health technologies, and hospitals are increasingly adopting smart devices for patient monitoring, diagnostics, and telemedicine services. This trend is driving demand for hospital supplies that support these digital health applications. .